Brodsky & Smith investigates PROS Holdings, Tourmaline Bio acquisitions.

Brodsky & Smith is investigating the acquisition of PROS Holdings by Thoma Bravo for $23.25 per share, valuing the company at $1.4 billion. The investigation focuses on whether the PROS Holdings Board breached its fiduciary duties by failing to conduct a fair process and whether the deal provides fair value to shareholders. Additionally, the firm is investigating the acquisition of Tourmaline Bio by SHCO.

The Ademi Firm has initiated an investigation into the acquisition of PROS Holdings Inc. (NYSE: PRO) by Thoma Bravo, which is valued at approximately $1.4 billion, or $23.25 per share. The investigation centers on whether the PROS Holdings Board breached its fiduciary duties in the transaction process and whether the deal provides fair value to shareholders.

The Ademi Firm, specializing in shareholder litigation involving buyouts and mergers, is examining whether the PROS board conducted a fair process and adequately fulfilled its fiduciary duties to all shareholders. The firm is also investigating whether the transaction agreement unreasonably limits competing transactions by imposing significant penalties if PROS accepts a competing bid.

In addition to the PROS acquisition, the Ademi Firm is also looking into the acquisition of Tourmaline Bio by SHCO. The investigation aims to ensure that shareholders of PROS and Tourmaline Bio receive fair compensation and that the acquisitions are conducted in the best interests of all shareholders.

For more information or to join the investigation, shareholders can contact the Ademi Firm toll-free at 866-264-3995.